Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants

The molecular manifestations of host cells responding to SARS-CoV-2 and its evolving variants of infection are vastly different across the studied models and conditions, imposing challenges for host-based antiviral drug discovery. Based on the postulation that antiviral drugs tend to reverse the glo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Jing, Shankar, Rama, Ko, Meehyun, Zhang, Keke, Zhang, Sulin, Drelich, Aleksandra, Paithankar, Shreya, Chekalin, Eugene, Chua, Mei-Sze, Rajasekaran, Surender, Kent Tseng, Chien-Te, Zheng, Mingyue, Kim, Seungtaek, Chen, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439871/
https://www.ncbi.nlm.nih.gov/pubmed/36093376
http://dx.doi.org/10.1016/j.isci.2022.105068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439871/
https://www.ncbi.nlm.nih.gov/pubmed/36093376
http://dx.doi.org/10.1016/j.isci.2022.105068

Ejemplares similares